The impact of regenerative therapies in the clinic with supporting evidence from the lab

Robert G. Audet, Robert B. Diller, Dominic Dominguez, Robert S Kellar

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Statement of Purpose: Axolotl Biologix is a regenerative medicine company that produces a stem cell-derived regenerative fluid (Axolotl Ambient™) and an amniotic membrane (Axolotl DualGraft™) that are used to promote wound healing and joint repair. In vitro bioassays are used to gain an understanding of the cellular processes that produce the clinical observations.

Original languageEnglish (US)
Title of host publicationSociety for Biomaterials Annual Meeting and Exposition 2019
Subtitle of host publicationThe Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting
PublisherSociety for Biomaterials
Number of pages1
ISBN (Electronic)9781510883901
StatePublished - Jan 1 2019
Event42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Seattle, United States
Duration: Apr 3 2019Apr 6 2019

Publication series

NameTransactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium
Volume40
ISSN (Print)1526-7547

Conference

Conference42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence
CountryUnited States
CitySeattle
Period4/3/194/6/19

Fingerprint

Ambystoma mexicanum
Bioassay
Stem cells
Repair
Membranes
Fluids
Industry
Amnion
Regenerative Medicine
Biological Assay
Wound Healing
Stem Cells
Therapeutics
Joints

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Biotechnology
  • Biomaterials
  • Materials Chemistry

Cite this

Audet, R. G., Diller, R. B., Dominguez, D., & Kellar, R. S. (2019). The impact of regenerative therapies in the clinic with supporting evidence from the lab. In Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium; Vol. 40). Society for Biomaterials.

The impact of regenerative therapies in the clinic with supporting evidence from the lab. / Audet, Robert G.; Diller, Robert B.; Dominguez, Dominic; Kellar, Robert S.

Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Society for Biomaterials, 2019. (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium; Vol. 40).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Audet, RG, Diller, RB, Dominguez, D & Kellar, RS 2019, The impact of regenerative therapies in the clinic with supporting evidence from the lab. in Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium, vol. 40, Society for Biomaterials, 42nd Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence, Seattle, United States, 4/3/19.
Audet RG, Diller RB, Dominguez D, Kellar RS. The impact of regenerative therapies in the clinic with supporting evidence from the lab. In Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Society for Biomaterials. 2019. (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium).
Audet, Robert G. ; Diller, Robert B. ; Dominguez, Dominic ; Kellar, Robert S. / The impact of regenerative therapies in the clinic with supporting evidence from the lab. Society for Biomaterials Annual Meeting and Exposition 2019: The Pinnacle of Biomaterials Innovation and Excellence - Transactions of the 42nd Annual Meeting. Society for Biomaterials, 2019. (Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium).
@inproceedings{36b9bd449a484200b891b8db3df9fbf4,
title = "The impact of regenerative therapies in the clinic with supporting evidence from the lab",
abstract = "Statement of Purpose: Axolotl Biologix is a regenerative medicine company that produces a stem cell-derived regenerative fluid (Axolotl Ambient™) and an amniotic membrane (Axolotl DualGraft™) that are used to promote wound healing and joint repair. In vitro bioassays are used to gain an understanding of the cellular processes that produce the clinical observations.",
author = "Audet, {Robert G.} and Diller, {Robert B.} and Dominic Dominguez and Kellar, {Robert S}",
year = "2019",
month = "1",
day = "1",
language = "English (US)",
series = "Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium",
publisher = "Society for Biomaterials",
booktitle = "Society for Biomaterials Annual Meeting and Exposition 2019",

}

TY - GEN

T1 - The impact of regenerative therapies in the clinic with supporting evidence from the lab

AU - Audet, Robert G.

AU - Diller, Robert B.

AU - Dominguez, Dominic

AU - Kellar, Robert S

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Statement of Purpose: Axolotl Biologix is a regenerative medicine company that produces a stem cell-derived regenerative fluid (Axolotl Ambient™) and an amniotic membrane (Axolotl DualGraft™) that are used to promote wound healing and joint repair. In vitro bioassays are used to gain an understanding of the cellular processes that produce the clinical observations.

AB - Statement of Purpose: Axolotl Biologix is a regenerative medicine company that produces a stem cell-derived regenerative fluid (Axolotl Ambient™) and an amniotic membrane (Axolotl DualGraft™) that are used to promote wound healing and joint repair. In vitro bioassays are used to gain an understanding of the cellular processes that produce the clinical observations.

UR - http://www.scopus.com/inward/record.url?scp=85065422630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065422630&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:85065422630

T3 - Transactions of the Annual Meeting of the Society for Biomaterials and the Annual International Biomaterials Symposium

BT - Society for Biomaterials Annual Meeting and Exposition 2019

PB - Society for Biomaterials

ER -